Clinical Trials Directory

Trials / Completed

CompletedNCT07167797

Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Baghdad · Academic / Other
Sex
All
Age
3 Months – 5 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the effect of vitamin D supplementation on the clinical outcomes including duration and severity of rotavirus-induced gastroenteritis in children that will be admitted to the hospital. And to evaluate the anti-inflammatory effect of vitamin D on the pediatrics with rotavirus gastroenteritis by measuring inflammatory markers such as C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), platelet to lymphocytes ratio (PLR), lymphocytes to monocytes ratio (LMR) and mean platelet volume MPV.

Detailed description

Evaluation of effect of vitamin D supplementation on the clinical outcomes including duration and severity of rotavirus-induced gastroenteritis in children that will be admitted to the hospital. And to evaluate the anti-inflammatory effect of vitamin D on the pediatrics with rotavirus gastroenteritis by measuring inflammatory markers such as C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), platelet to lymphocytes ratio (PLR), lymphocytes to monocytes ratio (LMR) and mean platelet volume MPV.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin D (Cholecalciferol )Group II (Treatment) group: received vitamin D single oral dose 100000 IU for age \< 1 year and dose of 300000IU for age\> 1 year in addition to standard treatment
DRUGStandard treatment for rotavirusStandard treatment for rotavirus which includes rehydration therapy and antipyretic therapy including sodium chloride fluid and paracetamol infusion

Timeline

Start date
2025-01-01
Primary completion
2025-05-01
Completion
2025-12-06
First posted
2025-09-11
Last updated
2025-12-31

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT07167797. Inclusion in this directory is not an endorsement.